1/29/25 20:43 | 1/27/25 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cheng Andrew | CA | DO | P,CEO | S | -1,647 | 54.90 | 0 | -30 | -4 | 716 | D | | | | | | | | | | | | | | |
1/27/25 18:07 | 1/23/25 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cheng Andrew | CA | DO | P,CEO | M.d | 31 | 0.6150 | 0 | 50 | 7 | 746 | D | | | | | | | | | | | | | | |
12/12/24 20:24 | 12/10/24 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cheng Andrew | CA | DO | P,CEO | S | -242 | 30.79 | 0 | -8 | -1 | 598 | D | | | | | | | | | | | | | | |
12/4/24 19:36 | 12/2/24 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cheng Andrew | CA | DO | P,CEO | M.d | 528 | 21.10 | 0 | 25 | 4 | 605 | D | | | | | | | | | | | | | | |
12/4/24 19:36 | 12/2/24 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cheng Andrew | CA | DO | P,CEO | S.d | -802 | 32.09 | 0 | -25 | -4 | 605 | D | | | | | | | | | | | | | | |
11/5/24 09:00 | 11/1/24 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cheng Andrew | CA | DO | P,CEO | M.d | 2,287 | 21.10 | 0 | 108 | 22 | 605 | D | | | | | | | | | | | | | | |
11/5/24 09:00 | 11/1/24 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cheng Andrew | CA | DO | P,CEO | S.d | -3,438 | 31.73 | 0 | -108 | -15 | 605 | D | | | | | | | | | | | | | | |
10/18/24 20:57 | 10/16/24 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cheng Andrew | CA | DO | P,CEO | M.dm | 1,933 | 21.10 | 0 | 92 | 18 | 605 | D | | | | | | | | | | | | | | |
10/18/24 20:57 | 10/16/24 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cheng Andrew | CA | DO | P,CEO | S.dm | -2,878 | 31.41 | 0 | -92 | -13 | 605 | D | | | | | | | | | | | | | | |
9/13/24 17:10 | 9/10/24 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cheng Andrew | CA | DO | P,CEO | S | -46 | 26.18 | 0 | -2 | 0 | 605 | D | | | | | | | | | | | | | | |
8/20/24 11:45 | 8/16/24 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cheng Andrew | CA | DO | P,CEO | M.d | 15 | 0.6150 | 0 | 25 | 4 | 607 | D | | | | | | | | | | | | | | |
6/13/24 18:01 | 6/11/24 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cheng Andrew | CA | DO | P,CEO | S | -179 | 22.64 | 0 | -8 | -1 | 582 | D | | | | | | | | | | | | | | |
3/15/24 16:43 | 3/13/24 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cheng Andrew | CA | DO | P,CEO | S | -56 | 28.33 | 0 | -2 | 0 | 589 | D | | | | | | | | | | | | | | |
3/6/24 20:14 | 3/4/24 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cheng Andrew | CA | DO | P,CEO | M.d | 1,288 | 17.17 | 0 | 75 | 15 | 591 | D | | | | | | | | | | | | | | |
3/6/24 20:14 | 3/4/24 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cheng Andrew | CA | DO | P,CEO | S.d | -2,465 | 32.87 | 0 | -75 | -11 | 591 | D | | | | | | | | | | | | | | |
1/3/24 17:00 | 1/2/24 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cheng Andrew | CA | DO | P,CEO | M.d | 25 | 0.6150 | 0 | 40 | 7 | 591 | D | | | | | | | | | | | | | | |
12/18/23 20:37 | 12/14/23 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cheng Andrew | CA | DO | P,CEO | S | -34 | 20.76 | 0 | -2 | 0 | 551 | D | | | | | | | | | | | | | | |
12/11/23 20:59 | 12/7/23 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cheng Andrew | CA | DO | P,CEO | M.dm | 172 | 6.36 | 0 | 27 | 5 | 553 | D | | | | | | | | | | | | | | |
12/11/23 20:59 | 12/7/23 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cheng Andrew | CA | DO | P,CEO | S.dm | -540 | 20.02 | 0 | -27 | -5 | 553 | D | | | | | | | | | | | | | | |
10/4/23 20:41 | 10/2/23 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cheng Andrew | CA | DO | P,CEO | M.d | 159 | 6.36 | 0 | 25 | 6 | 461 | D | | | | | | | | | | | | | | |
10/4/23 20:41 | 10/2/23 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cheng Andrew | CA | DO | P,CEO | S.d | -1,198 | 47.91 | 0 | -25 | -5 | 461 | D | | | | | | | | | | | | | | |
9/25/23 20:36 | 9/13/23 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cheng Andrew | CA | DO | P,CEO | S | -85 | 50.34 | 0 | -2 | 0 | 461 | D | | | | | | | | | | | | | | |
9/18/23 18:48 | 9/1/23 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cheng Andrew | CA | DO | P,CEO | M.d | 159 | 6.36 | 0 | 25 | 6 | 463 | D | | | | | | | | | | | | | | |
9/18/23 18:48 | 9/1/23 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cheng Andrew | CA | DO | P,CEO | S.d | -1,244 | 49.77 | 0 | -25 | -5 | 463 | D | | | | | | | | | | | | | | |
8/30/23 19:04 | 8/30/23 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cheng Andrew | CA | DO | P,CEO | M.d | 9 | 0.6150 | 0 | 15 | 3 | 463 | D | | | | | | | | | | | | | | |
8/3/23 16:13 | 8/1/23 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cheng Andrew | CA | DO | P,CEO | M.d | 159 | 6.36 | 0 | 25 | 6 | 448 | D | | | | | | | | | | | | | | |
8/3/23 16:13 | 8/1/23 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cheng Andrew | CA | DO | P,CEO | S.d | -1,079 | 43.15 | 0 | -25 | -5 | 448 | D | | | | | | | | | | | | | | |
7/6/23 20:44 | 7/3/23 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cheng Andrew | CA | DO | P,CEO | M.d | 159 | 6.36 | 0 | 25 | 6 | 448 | D | | | | | | | | | | | | | | |
7/6/23 20:44 | 7/3/23 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cheng Andrew | CA | DO | P,CEO | S.d | -1,122 | 44.88 | 0 | -25 | -5 | 448 | D | | | | | | | | | | | | | | |
6/27/23 19:12 | 6/27/23 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cheng Andrew | CA | DO | P,CEO | M.d | 25 | 0.6150 | 0 | 40 | 10 | 448 | D | | | | | | | | | | | | | | |
6/15/23 21:38 | 6/13/23 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cheng Andrew | CA | DO | P,CEO | S | -89 | 55.16 | 0 | -2 | 0 | 408 | D | | | | | | | | | | | | | | |
6/5/23 18:23 | 6/1/23 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cheng Andrew | CA | DO | P,CEO | M.d | 36 | 1.46 | 0 | 25 | 7 | 409 | D | | | | | | | | | | | | | | |
6/5/23 18:23 | 6/1/23 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cheng Andrew | CA | DO | P,CEO | S.d | -1,127 | 45.10 | 0 | -25 | -6 | 409 | D | | | | | | | | | | | | | | |
5/3/23 20:28 | 4/18/23 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cheng Andrew | CA | DO | P,CEO | M.dm | 40 | 0.6150 | 0 | 65 | 19 | 409 | D | | | | | | | | | | | | | | |
5/3/23 20:28 | 5/1/23 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cheng Andrew | CA | DO | P,CEO | S.d | -1,127 | 45.07 | 0 | -25 | -6 | 409 | D | | | | | | | | | | | | | | |
4/5/23 16:55 | 4/3/23 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cheng Andrew | CA | DO | P,CEO | M.d | 15 | 0.6150 | 0 | 25 | 7 | 369 | D | | | | | | | | | | | | | | |
4/5/23 16:55 | 4/3/23 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cheng Andrew | CA | DO | P,CEO | S.d | -949 | 37.94 | 0 | -25 | -6 | 369 | D | | | | | | | | | | | | | | |
3/3/23 16:21 | 3/1/23 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cheng Andrew | CA | DO | P,CEO | M.d | 15 | 0.6150 | 0 | 25 | 7 | 371 | D | | | | | | | | | | | | | | |
3/3/23 16:21 | 3/1/23 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cheng Andrew | CA | DO | P,CEO | S.d | -1,166 | 46.65 | 0 | -25 | -6 | 371 | D | | | | | | | | | | | | | | |
2/3/23 17:25 | 2/1/23 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cheng Andrew | CA | DO | P,CEO | M.d | 15 | 0.6150 | 0 | 25 | 7 | 371 | D | | | | | | | | | | | | | | |
2/3/23 17:25 | 2/1/23 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cheng Andrew | CA | DO | P,CEO | S.d | -1,226 | 49.06 | 0 | -25 | -6 | 371 | D | | | | | | | | | | | | | | |
1/5/23 18:46 | 1/3/23 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cheng Andrew | CA | DO | P,CEO | M.d | 15 | 0.6150 | 0 | 25 | 7 | 371 | D | | | | | | | | | | | | | | |
1/5/23 18:46 | 1/3/23 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cheng Andrew | CA | DO | P,CEO | S.d | -1,282 | 51.27 | 0 | -25 | -6 | 371 | D | | | | | | | | | | | | | | |
12/20/22 19:46 | 12/16/22 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cheng Andrew | CA | DO | P,CEO | M.d | 5 | 0.6150 | 0 | 9 | 2 | 371 | D | | | | | | | | | | | | | | |
12/2/22 17:52 | 12/1/22 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cheng Andrew | CA | DO | P,CEO | M.d | 6 | 0.6150 | 0 | 10 | 3 | 310 | D | | | | | | | | | | | | | | |
12/2/22 17:52 | 12/1/22 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cheng Andrew | CA | DO | P,CEO | S.d | -461 | 46.07 | 0 | -10 | -3 | 310 | D | | | | | | | | | | | | | | |
11/2/22 21:52 | 11/1/22 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cheng Andrew | CA | DO | P,CEO | M.d | 6 | 0.6150 | 0 | 10 | 3 | 310 | D | | | | | | | | | | | | | | |
11/2/22 21:52 | 11/1/22 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cheng Andrew | CA | DO | P,CEO | S.d | -434 | 43.42 | 0 | -10 | -3 | 310 | D | | | | | | | | | | | | | | |
10/5/22 08:55 | 10/3/22 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cheng Andrew | CA | DO | P,CEO | M.d | 6 | 0.6150 | 0 | 10 | 3 | 310 | D | | | | | | | | | | | | | | |
10/5/22 08:55 | 10/3/22 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cheng Andrew | CA | DO | P,CEO | S.d | -332 | 33.23 | 0 | -10 | -3 | 310 | D | | | | | | | | | | | | | | |
9/15/22 19:59 | 9/13/22 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cheng Andrew | CA | DO | P,CEO | M.d | 37 | 0.6150 | 0 | 60 | 24 | 310 | D | | | | | | | | | | | | | | |
9/15/22 19:59 | 9/13/22 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cheng Andrew | CA | DO | P,CEO | S.d | -1,645 | 27.42 | 0 | -60 | -16 | 310 | D | | | | | | | | | | | | | | |
3/2/22 20:40 | 3/1/22 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cheng Andrew | CA | DO | P,CEO | M.d | 6 | 0.6150 | 0 | 10 | 3 | 309 | D | | | | | | | | | | | | | | |
3/2/22 20:40 | 3/1/22 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cheng Andrew | CA | DO | P,CEO | S.d | -176 | 17.59 | 0 | -10 | -3 | 309 | D | | | | | | | | | | | | | | |
2/3/22 19:12 | 2/1/22 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cheng Andrew | CA | DO | P,CEO | M.d | 6 | 0.6150 | 0 | 10 | 3 | 309 | D | | | | | | | | | | | | | | |
2/3/22 19:12 | 2/1/22 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cheng Andrew | CA | DO | P,CEO | S.d | -176 | 17.56 | 0 | -10 | -3 | 309 | D | | | | | | | | | | | | | | |
1/11/22 21:40 | 1/10/22 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cheng Andrew | CA | DO | P,CEO | M.d | 6 | 0.6150 | 0 | 10 | 3 | 299 | D | | | | | | | | | | | | | | |
1/11/22 21:40 | 1/10/21 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cheng Andrew | CA | DO | P,CEO | S.d | -196 | 19.55 | 0 | -10 | -3 | 299 | D | | | | | | | | | | | | | | |
1/4/22 21:21 | 1/3/22 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cheng Andrew | CA | DO | P,CEO | M.d | 33 | 0.6150 | 0 | 53 | 21 | 309 | D | | | | | | | | | | | | | | |
12/3/21 17:20 | 12/2/21 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cheng Andrew | CA | DO | P,CEO | S | -353 | 20.18 | 0 | -18 | -6 | 256 | D | | | | | | | | | | | | | | |
11/3/21 16:16 | 11/2/21 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cheng Andrew | CA | DO | P,CEO | S | -395 | 22.57 | 0 | -18 | -6 | 273 | D | | | | | | | | | | | | | | |
10/5/21 16:11 | 10/4/21 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cheng Andrew | CA | DO | P,CEO | S | -377 | 21.54 | 0 | -18 | -6 | 291 | D | | | | | | | | | | | | | | |
9/3/21 16:37 | 9/2/21 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cheng Andrew | CA | DO | P,CEO | S | -418 | 23.89 | 0 | -18 | -5 | 308 | D | | | | | | | | | | | | | | |
8/4/21 17:38 | 8/3/21 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cheng Andrew | CA | DO | P,CEO | S | -365 | 20.83 | 0 | -18 | -5 | 326 | D | | | | | | | | | | | | | | |
7/6/21 17:52 | 7/2/21 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cheng Andrew | CA | DO | P,CEO | S | -434 | 24.78 | 0 | -18 | -5 | 342 | D | | | | | | | | | | | | | | |
1/11/21 19:57 | 1/7/21 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cheng Andrew | CA | DO | P,CEO | M.d | 12 | 0.6150 | 0 | 20 | 6 | 360 | D | | | | | | | | | | | | | | |
12/29/20 16:53 | 12/28/20 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cheng Andrew | CA | DO | P,CEO | M.d | 5 | 0.6200 | 0 | 7 | 2 | 343 | D | | | | | | | | | | | | | | |
12/23/20 16:19 | 12/21/20 | AKRO | Akero Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cheng Andrew | CA | DO | P,CEO | M.d | 7 | 0.6200 | 0 | 11 | 3 | 336 | D | | | | | | | | | | | | | | |